UK markets closed

BioPorto A/S (BIOPOR.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
1.4300+0.0400 (+2.88%)
At close: 04:47PM CEST
Full screen
Previous close1.3900
Open1.4080
Bid1.4240 x 0
Ask1.4200 x 0
Day's range1.4060 - 1.4360
52-week range1.0020 - 4.1000
Volume181,800
Avg. volume483,191
Market cap478.592M
Beta (5Y monthly)1.22
PE ratio (TTM)N/A
EPS (TTM)-0.2140
Earnings date09 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    BioPorto to Participate in H.C. Wainwright’s 24th Annual Global Investment Conference

    COPENHAGEN, Denmark and BOSTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced plans to participate in the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022 in New York City. Following are details for management’s presentation: Date: September 12, 2022 Time: Available On Demand at 7am ET Webcast Link: https://journey.ct.events/view/2785e18a-7a71-4dd6-a735-695045a60f04 Management will also be available for 1x1 meet

  • Globe Newswire

    BioPorto Announces Interim Results for the First Six Months of 2022

    August 17, 2022Announcement no. 13 BioPorto Announces Interim Results for the First Six Months of 2022 COPENHAGEN, DENMARK and BOSTON, MA, USA, August 17, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first six months of 2022 and business progress for the second quarter of 2022. Recent Highlights For the six months ending June 30, 2022: Total revenue of DKK 15.0 million / USD 2.2 million, a 23% increase over the prior yearAdjuste

  • Globe Newswire

    BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call

    August 8, 2022News release BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call COPENHAGEN, DENMARK and BOSTON, MA, USA, August 8, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury, announced today that in connection with the release of its Interim Report for the second quarter of 2022, the Company’s management team will host an online investor presentation on August